| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2778 |
Injection, ranibizumab, 0.1 mg |
4,763 |
3,730 |
$2.40M |
| J0178 |
Injection, aflibercept, 1 mg |
1,174 |
1,108 |
$1.12M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
8,605 |
7,812 |
$314K |
| 92134 |
|
11,227 |
10,477 |
$132K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
2,692 |
2,578 |
$72K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
893 |
865 |
$39K |
| 92250 |
|
1,038 |
1,005 |
$18K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
235 |
222 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
741 |
701 |
$14K |
| 92235 |
|
317 |
312 |
$11K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
443 |
407 |
$10K |
| J9035 |
Injection, bevacizumab, 10 mg |
151 |
139 |
$10K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
12 |
12 |
$6K |
| 99426 |
|
20 |
20 |
$0.00 |